Zhejiang Tianyu Pharmaceutical Hits Day High with Strong 6.05% Surge

Zhejiang Tianyu Pharmaceutical Co., Ltd. has experienced a notable increase of 6.05% on March 27, 2026, reaching an intraday high of CNY 23.40. This performance stands out against the backdrop of the China Shanghai Composite, which saw a modest gain of 0.63% on the same day. Over the past week, Zhejiang Tianyu has shown a solid performance with a 6.0% increase, contrasting with a decline of 1.09% in the broader market. However, the stock has faced challenges over the longer term, with a 5-year performance decline of 59.2%. Despite this, the company reported a significant growth in net sales, which rose by 22.92% in the first half of the year, alongside a notable increase in net profit of 12.78%. The company maintains a market capitalization of CNY 5,163 million and a price-to-earnings ratio of 59.00. With a return on equity of 5.15% and a dividend yield of 0.34%, Zhejiang Tianyu continues to navigate a competitive landscape in the pharmaceuticals and biotechnology sector.